| NY-ESO-1 based immunotherapy of cancer: current perspectives R Thomas, G Al-Khadairi, J Roelands, W Hendrickx, S Dermime, ... Frontiers in immunology 9, 947, 2018 | 378 | 2018 |
| Matrix metalloproteinases: protective roles in cancer J Decock, S Thirkettle, L Wagstaff, DR Edwards Journal of cellular and molecular medicine 15 (6), 1254-1265, 2011 | 230 | 2011 |
| Immune checkpoints in the tumor microenvironment SM Toor, VS Nair, J Decock, E Elkord Seminars in cancer biology, 2019 | 180 | 2019 |
| Immunogenomic classification of colorectal cancer and therapeutic implications J Roelands, PJK Kuppen, L Vermeulen, C Maccalli, J Decock, E Wang, ... International journal of molecular sciences 18 (10), 2229, 2017 | 140 | 2017 |
| Immune checkpoint inhibitors in triple negative breast cancer treatment: promising future prospects R Thomas, G Al-Khadairi, J Decock Frontiers in Oncology 10, 3464, 2020 | 130 | 2020 |
| Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive B Van Calster, I Vanden Bempt, M Drijkoningen, N Pochet, J Cheng, ... Breast cancer research and treatment 113, 181-187, 2009 | 126 | 2009 |
| Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis J Decock, JR Long, RC Laxton, XO Shu, C Hodgkinson, W Hendrickx, ... Cancer research 67 (21), 10214-10221, 2007 | 121 | 2007 |
| The roles of ADAMTS metalloproteinases in tumorigenesis and metastasis L Wagstaff, R Kelwick, J Decock, DR Edwards Front Biosci 16 (1), 1861-1872, 2011 | 107 | 2011 |
| Plasma MMP1 and MMP8 expression in breast cancer: protective role of MMP8 against lymph node metastasis J Decock, W Hendrickx, U Vanleeuw, V Van Belle, S Van Huffel, ... BMC cancer 8, 1-8, 2008 | 101 | 2008 |
| Cancer Testis Antigens and Immunotherapy: Where Do We Stand in the Targeting of PRAME? G Al-Khadairi, J Decock Cancers 11 (7), 984, 2019 | 97 | 2019 |
| Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer J Decock, N Obermajer, S Vozelj, W Hendrickx, R Paridaens, J Kos The International journal of biological markers 23 (3), 161-168, 2008 | 92 | 2008 |
| TGF-β-elicited induction of tissue inhibitor of metalloproteinases (TIMP)-3 expression in fibroblasts involves complex interplay between Smad3, p38α, and ERK1/2 SK Leivonen, K Lazaridis, J Decock, A Chantry, DR Edwards, VM Kähäri PLoS One 8 (2), e57474, 2013 | 87 | 2013 |
| Matrix metalloproteinase 8 (collagenase 2) induces the expression of interleukins 6 and 8 in breast cancer cells S Thirkettle, J Decock, H Arnold, CJ Pennington, DM Jaworski, ... Journal of Biological Chemistry 288 (23), 16282-16294, 2013 | 82 | 2013 |
| Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer J Decock, R Paridaens, S Ye Clinical genetics 73 (3), 197-211, 2008 | 82 | 2008 |
| The obesity paradox in cancer, tumor immunology, and immunotherapy: potential therapeutic implications in triple negative breast cancer A Naik, AM Monjazeb, J Decock Frontiers in immunology 10, 1940, 2019 | 73 | 2019 |
| Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response J Roelands, W Hendrickx, G Zoppoli, R Mall, M Saad, K Halliwill, ... Journal for immunotherapy of cancer 8 (1), 2020 | 67 | 2020 |
| PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer G Al-Khadairi, A Naik, R Thomas, B Al-Sulaiti, S Rizly, J Decock Journal of translational medicine 17, 1-14, 2019 | 57 | 2019 |
| Metalloproteinase‐dependent and‐independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and … R Kelwick, L Wagstaff, J Decock, C Roghi, LS Cooley, SD Robinson, ... International journal of cancer 136 (4), E14-E26, 2015 | 56 | 2015 |
| Proteases and metastasis: clinical relevance nowadays? J Decock, R Paridaens, T Cufer Current opinion in oncology 17 (6), 545-550, 2005 | 51 | 2005 |
| The MAPK hypothesis: immune-regulatory effects of MAPK-pathway genetic dysregulations and implications for breast cancer immunotherapy D Bedognetti, J Roelands, J Decock, E Wang, W Hendrickx Emerging Topics in Life Sciences 1 (5), 429-445, 2017 | 50 | 2017 |
Wouter HendrickxSidra MedicineVerified email at sidra.org
